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Asthma from childhood to adulthood:
asthma severity, allergies, sensitization, living
conditions, gender influence and social consequences
B. KJELLMAN AND P. M. GUSTAFSSON
Department of Paediatrics, Central Hospital, Sko¨vde, Sweden
The course of asthma severity, clinical allergies, allergic sensitization, changes in living conditions and social
outcome were studied prospectively over five follow-up visits from the mean age of 9 to 30 years in a cohort of 28
boys and 27 girls, selected randomly among asthmatic children attending a paediatric outpatient unit.
Asthma severity improved from childhood to adulthood, judged by symptom and medication scores and by
the number of hospital admissions, but only nine subjects (16%) had been free from symptoms and medication over
the last year of follow-up. After adolescence, asthma continued to improve among the males but not among the
females. This dierence could not be explained by gender dierences in the course of clinical allergies or
sensitization (skin-prick-tests and RAST) to common inhaled allergens, or by dierences in environmental or social
conditions. Sensitization to relevant perennial inhaled allergens correlated with asthma severity during adulthood.
In general, clinical allergies and sensitization to inhaled allergens adopted during childhood persisted into
adulthood. Approximately 10% of the subjects never adopted a clinical allergy or a positive allergy test. The social
outcome was good.
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Information from long-term follow-up studies of children
with asthma is invaluable when educating patients and
parents on the likely outcome of asthma and the future
quality of life for the patient. Longitudinal studies on the
course of asthma can also help us understand why the
disease remains or resolves in dierent subjects, particularly
when they include information on a wide range of possible
influencing factors.
During childhood, asthma is more prevalent among boys
than girls (1,2), whilst in adulthood asthma is more
frequent among women (3,4). Female gender has been
found to be an important risk factor for developing asthma
in young adulthood (5) and, furthermore, there are studies
indicating that asthma is more severe in adult females than
males (6,7). Possible gender-related changes in asthma
severity during the course of the disease from childhood to
adulthood have not been reported in detail in previous
prospective studies. Furthermore, it is not known if theReceived 13 July 1999 and accepted in revised form 25 November
1999.
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0954-6111/00/050454+12 $35?00/0gender dierence in severity is related to the course and
outcome of allergy and sensitization or to environmental
factors.
Approximately 85% of asthmatic school children have
concomitant allergy to inhaled allergens. Sensitization and
clinical allergy to basic food stus like egg-white and cow’s
milk develop mostly during infancy, and generally dis-
appear after a few years (8–10). Reactions and sensitization
to inhaled allergens generally appear later, and tolerance
does not seem to develop during childhood or adolescence,
as we have reported in earlier studies (9,10). It has not been
made clear if or when tolerance to inhaled allergens
develops during adulthood. In a previous report on the
present cohort of 55 asthmatic children, we found a slight
tendency to reduced clinical allergy to pollens but not to
animal danders when the mean age of the group was 24
years (11). Whilst atopic allergy is a risk factor for asthma
development and asthma severity in early childhood (12–
15), the importance of associated clinical allergy and
sensitization for asthma severity in older children and
adults is not as clear (16–22).
Prospective, longitudinal studies are ideally suited to
delineate the course of asthma. Participants in long-term
follow-up studies on asthma may be recruited from patients
attending health care facilities, from the general population
or from birth cohorts. A large number of studies on the# 2000 HARCOURT PUBLISHERS LTD
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published and were reviewed by Roorda (23) and by Grol et
al. (24). Several studies on asthma outcome suer from not
being prospective (33 of 55 studies in the Grol review) or
from being only questionnaire-based (28 of 55 studies the in
Grol review). Other studies included highly selected groups
of asthma patients, included only single or a few follow-up
sessions, or had lost many patients at follow-up. Few
prospective long-term studies on asthma from childhood to
adulthood incorporate several interim evaluations or
include wide aspects on the course of the disease (25,26).
This is a report on the course of asthma in a cohort of 55
asthmatic school children, recruited from a paediatric out-
patient unit and who attended all five follow-up visits over
two decades up to the mean age of 30 years. Two interim
reports have been published previously (11,27). The aims of
the present study were to determine the course of asthma
from childhood to adult life, taking into account disease
severity, and associated clinical allergies and sensitization,
to describe changes in living conditions, to assess social
consequences from asthma, to study changes of lung
function and to evaluate possible gender dierences in
these aspects. In this article we describe the course and
outcome of all these variables except for lung function,
which is reported in a companion paper (28).
Study subjects
The source for patient recruitment to this prospective study
consisted of all asthmatic children (n&160) referred during
the period from autumn 1973 to springtime 1976 to the
Paediatric Allergy Outpatient Unit at the Central Hospital
of Sko¨vde, Sweden. This unit serves a geographically
determined area and its population of approximately
200 000. The indications for referral from general practi-
tioners and paediatricians to the unit were well establishedTABLE 1. Visit year, age of subjects, and interval between six vis
with childhood asthma. Statistical evaluations refer to comparis
Age (years)
Visit no. Visit year Gender Mean Range
I 1974/76 M 92 57–144
F 96 47–138
II 1976/78 M 110 80–166
F 121 72–167
III 1978/80 M 131 99–185
F 141 91–187
IV 1983 M 172 139–227
F 172 127–218
V 1990 M 243 211–297
F 242 195–289
VI 1985/96 M 300 269–354
F 301 254–348in the area, and stated that all children above the age of 3
years with a history of at least three episodes of wheezing
should be referred for asthma and allergy evaluation. Three
or more episodes of wheezing were used for a diagnosis of
asthma in accordance with Buum (29). This was a
commonly used asthma criterion in Sweden during the
1970s. The routine work-up at the unit consisted of a
history using a standardized questionnaire, scrutiny of all
previous records, a physical examination and a skin-prick
test (SPT).
A cohort of asthmatic children was randomly selected
from the patients referred during this period with the
intention to include half boys and half girls (for gender
comparison) and to include patients who would be at least 7
years old, in order to be able to perform spirometry at the
first follow-up, scheduled to 1977/78. Twenty-nine girls and
29 boys were asked to participate, but one girl and her
parents did not give consent to follow-ups in addition to
visits to her ordinary doctor, and one boy did not fulfil the
criteria of asthma mentioned above. The remaining 56
children and their parents gave consent for the planned
long-term follow-up, which was superimposed on their
ordinary care programme and which was to include
repeated SPTs, venous punctures for serum IgE antibody
determinations, and spirometry before and after inhalation
of salbutamol. Fifty-five of the 56 children fulfilling the
inclusion criteria and giving consent reported for all five
follow-up visits and this report encompasses these 55
subjects (Table 1). The fifty-sixth child, a girl, died during
an asthma attack at the age of 16 years, between the second
and third follow-up visits. At the initial visit to the unit
(designated I) the mean age of the participants was 9 years.
The study period from this visit, used for allocation, ranged
over 21 years and included five follow-up visits, designated
II–VI. The ages of the females and males were similar at all
visits, but the interval from the previous visit diered
slightly at visits II, IV and VI (Table 1). Onset of wheezingits (I–VI) in the follow-up study of 28 males and 27 females
ons between males and females
Interval from previous visit (years)




n.s 25 06–41 5005
20 18–23
n.s. 20 18–21 n.s.
41 38–46
n.s. 32 27–37 50001
71 67–74
n.s. 70 65–76 n.s.
57 54–60
n.s. 58 55–60 50001
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between 2 and 7 years in 42% (retrospective data)
according to information obtained at visit I, supported by
various health records, and confirmed at visit II. All
children had experienced at least one episode of bronchial
obstruction the year prior to visit I. At this visit the
occurrence of atopic dermatitis was 37% in the girls and
30% in the boys (n.s.), and of seasonal rhinitis 44% in the
girls and 39% in the boys (n.s.). Four girls and four boys
had continuous use of inhaled sodium cromoglycate
(inhaled corticosteroids were not prescribed at that time).
Methods
At all visits (I–VI) a history was taken using a standardized
questionnaire emphasizing the frequency and severity of
asthmatic symptoms, allergic reactions and other atopic
manifestations, and environmental and social issues. One of
the authors (B.K.) participated in the evaluations through-
out the study. Records from visits to well-baby clinics, out-
patient clinics or from hospital wards, before as well as
during the study, were scrutinized. A physical examination,
and SPT to common inhaled allergens were undertaken at
all visits. Total serum IgE and specific serum IgE antibody
concentrations to inhaled allergens and lung function were
determined at visits II–VI. For routine check-ups for
asthma and allergy between the follow-up visits the patients
attended their ordinary doctors (general practitioners or
paediatricians). With a few exceptions, the examinations
were performed during late autumn, winter or early spring
before the pollen season. The visits were timed to allow the
patients to be in optimal condition. Height was measured at
each follow-up with a stadiometer, and the deviation from
predicted height for age and sex was calculated and
presented as standard deviation scores (SDS) (30). Aberrant
growth was arbitrarily defined as a drop in height of at least
one SDS between any two follow-up visits. Two examina-
tions were added during the follow-up period: home visits
by a trained and experienced allergy nurse in connection
with visit III; and determinations of carbon-monoxide
concentrations in exhaled air at visit VI by use of a portable
CO-analyser (CO Monitor, Bedford Scientific Ltd, U.K.).
DEFINITIONS
A hospital ‘admission’ for asthma was defined as a stay
longer than eight hours in a hospital ward. ‘Atopic
dermatitis’ (AD) was defined as a non-infectious, chronic
or chronic relapsing pruritic dermatitis with age-related
typical morphology and distribution, thus in accordance
with the suggestions by, for example, Hanifin and Rajka
(31), but was judged solely by its appearance and without
regard to total serum IgE levels or the occurrence of
positive allergy tests. ‘Asthma severity’ was estimated from
visit II and onwards according to the frequency of wheezing
and the degree of medication reported from the 12-month
period prior to each follow-up. Severity was graded using a
symptom score (0–3 p) and a medication score (0–3 p),
producing a total asthma score of 0–6 p. ‘Symptom score’ 1implies occasional wheezing in connection with respiratory
tract infections, heavy exposure to allergens, and/or hard
physical exercise. Symptom score 2 denotes wheezing up to
twice a week, and/or after ordinary physical exercise, such
as ordinary school athletics. Score 3 implies wheezing more
than twice a week and/or impairment of daily physical
activities. Score 0 denotes the absence of wheezing over the
whole year before the visit. ‘Medication score 1’ implies
occasional use of bronchodilators for symptomatic relief
and/or the use of inhaled sodium cromoglycate or steroids
for less than 3 months a year over the year prior to the visit.
Medication scores 2 and 3 denote the use of bronchodila-
tors when needed and continuous use of one (score 2) or
two drugs (score 3) for asthma control. Score 0 implies no
use of anti-asthmatic medication over the year prior to the
visit. Over the whole study the general policy of medication
was similar, i.e. aiming at enabling the patient to take part
in all activities of ordinary life, including sports, without
wheezing. This implied that the patient should use one or
several drugs continuously for asthma control, in accor-
dance with the current pharmacology policy, if wheezing
occurred several times a week. ‘Clinical allergy’ was
estimated at all visits by questioning the occurrence of
clinical reactions to pollens, danders or food. Clinical
allergy against furred animals was defined as obvious
reactions from the eyes, the nose or the lower respiratory
tract within 1 h after exposure to a furred animal, and when
first reported such symptoms had to occur at least twice.
Clinical allergy to pollen was defined as obvious reactions,
not related to respiratory tract infections, from the eyes, the
nose or the lower respiratory tract during the pollen season
and when first reported, such symptoms had to occur for at
least two seasons to be noted. Current allergy to pollen
at the follow-up visits was defined as such symptoms during
at least one of the two preceding seasons and allergy to
animal danders was present if symptoms had occurred
during the last 12-month period. Allergy to food was
defined as obvious reactions which had occurred in the
respiratory or gastrointestinal tract or in the skin within
approximately 1 h after exposure, and had to occur twice
initially to be recorded.
These definitions are similar to those used in other
prospective, long-term cohort studies performed by us and
starting during the late 1970s and the 1980s (8–10). The
retrospectively obtained information on symptoms and
events occurring before joining the study was based on
patient records and standardized patients questionnaires
used in the unit at visit I. These data were scrutinized at
visit II especially with regard to the asthma and allergy
criteria, and living conditions.
SKIN-PRICK TESTS
SPTs were performed on the volar aspect of the forearm by
the same nurse at visit I to V and by another nurse,
educated by the previous nurse, at visit VI. Histamine
solution (10g l71) and 0.9% saline were used as positive
and negative references, respectively. A weal with a mean
diameter (half the sum of the largest diameter and its
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as positive, if the saline control was negative. Calculation of
the discriminating power of histamine to saline was done at
visit VI and showed diameters above 3 mm in all the
histamine weals and in none of the saline weals. The mean
diameter of the histamine weals was 6.7 mm and the
coecient of variation (CV) of duplicates was 14%.
At all visits the following allergens were tested: birch
(Betula verucosa), grass (Phleum pratense), cat (Felis
domesticus), dog (Canis domesticus), horse (Equus cabellus),
house dust mites and moulds. Pollen and dander extracts
(aqueous extracts, 1/10 w/v) produced by Vitrum AB
(Stockholm, Sweden) were used at visit I. Extracts from
Dome Hollister Stier, UK (500 protein nitrogen units ml71)
were used at visits II and III. At visits IV to VI the extracts
used were produced by Pharmacia Diagnostica (Uppsala,
Sweden) or ALK (Copenhagen, Denmark) in concentra-
tions of 10 Heparin Equivalent Potency (HEP), corre-
sponding to 10 000 biological units ml71. Aqueous mould
extracts (1/20, w/v) were used.
At visit VI the precision of SPT was evaluated by
duplicate SPTs, using corresponding areas of the contral-
ateral arm. The mean values (mm) of the weal diameters in
subjects with positive reactions were 66 for birch, 79 for
timothy, 88 for cat, 68 for dog, 81 for horse, 51 for D.
pteronyssinus, and 42 D. farinae. The coecients of
variation, expressed as percentages of the mean diameter
were 23 for birch, 19 for timothy, 24 for cat, 15 for dog, 24
for horse, 20 for D. pteronyssinus and 14 for D. farinae. A
change from a positive to a negative test or vice versa in the
duplicate testing was seen in the following number of
subjects: three for birch, two for timothy, one for dog, cat
and horse, respectively, and none for mites.
SERUM LEVELS OF TOTAL AND SPECIFIC
IGE
These tests were done from visit II onwards in the same
laboratory (Department of Clinical Chemistry/Lab Novo-
Calab, Central Hospital, Sko¨vde) and by the same
assistants. Due to an administrative error, the first 14
serum specimens were lost at visit II. Total serum IgE
concentrations were estimated with the Phadebas PRIST
(Pharmacia Diagnostica, Uppsala, Sweden) from visits II to
V, and with the Phadebas CAP method at visit VI (paper
discs were not available). The CVs for IgE determinations
in our laboratory varied between 10 and 15% during the
late 1970s and the 1980s, and was 84% at visit VI, based on
duplicate tests from the first 15 subjects investigated.
Specific serum IgE antibodies were determined with
Phadebas RAST (Pharmacia Diagnostica, Uppsala, Swe-
den) except for one allergen (horse) on one occasion (visit
VI), when the Phadebas CAP method was used (paper discs
not available). The RAST class rating 0–4 was used, i.e. a
positive RAST implies an arbitrary concentration of 035
PRU ml71. The further limits were: 070, 35 and
17 PRU ml71. IgE antibodies to the following antigens
were determined at visit II to VI: birch, timothy, hazel, dog,
cat, horse, cow, D. pteronyssinus and moulds. Tests for D.farinae were added from visits IV to VI, and at visit V tests
for Lepidoglyphus destructor. At visit VI all sera were also
analysed for IgE antibodies to egg-white.
During the late 1970s and during the 1980s, the CVs for
RAST obtained in this laboratory varied between 15 and
24%. At visit VI duplicate RASTs were analysed in the first
10 subsequent subjects for the following allergens: birch,
dog, cat, D. pteronyssinus, D. farinae, the mould mixture
and for horse allergen. The number of subjects with a
change from positive to negative or vice versa was one for
birch and one for dog (from 040–030 PRU ml71) and
none for the remaining allergens. The number of subjects
with a change from one RAST-class to another was one for
cat (36 to 34 PRU ml71) and one for D. pteronyssinus
(08–06 PRU ml71).
STATISTICS
Equality between non-paired proportions was asessed with
the w2-test or the Fisher’s exact test if an expected cell value
was less than five. The McNemar’s test was used for paired
observations. The P-values, the odds ratios (OR) and the
95% confidence intervals (CI) are given. Analysis of
equality between unpaired sets of data were calculated with
the Mann–Whitney test and between paired sets with the
Wilcoxon matched pairs signed ranks test. Not significant
(n.s.) implies a P 005.
ETHICS
The ethical committee at the Central Hospital in Sko¨vde
initially approved the study. During childhood and
adolescence the children and their parents gave their
informed consent before every follow-up. In adulthood,
informed consent was received from all study subjects.
Results
ASTHMA SCORES
For the whole group the total asthma scores (Fig. 1) peaked
at visit III and then declined over the subsequent follow-up
visits. The increase from visit II to III was not significant.
From visit III, total asthma scores decreased significantly to
visit IV (P=0039), visit V (P=002) and visit VI
(P=0002). Significant reductions were also seen from visit
II to VI (P=0005) and from visit IV to VI (P=0013). For
the males, the total asthma scores dropped subsequently
from visit III. The decline to visit VI was significant from
visit II (P50001), III (P50001), IV (P=0003) and V
(P=0004). Among the females, a significant increase in
total asthma score was seen from visit II to III (P=0033),
and tendencies to reduced total asthma scores were seen
from visit III to visits IV and V, but in contrast to the
findings among the males total scores tended to increase
among females from visit V to VI.
The symptom scores in males decreased significantly from
visit II (P=0005), III (P=0032), and V (P=0037) to visit
FIG. 1. Mean total asthma scores for males (n=28) and
females (n=27) and both sexes combined from visit II to
VI. For definitions see Methods.
*P5005; **P5001; ***P50001, visit II–V vs. visit VI,
both sexes. {{P5001; {{{P50001, visit II–V vs. visit VI,
males only. #P5005 visit II vs. III, females only. }P5005,
males vs. females, visit II.
TABLE 2. Height (standard deviation score; SDS) in 28 male
(M) and 27 female (F) subjects obtained at visits II–V.
Mean, maximum and minimum values are given
Visit no.
II III IV V
Mean M +02 +03 +01 +02
F 00 701 00 00
Maximum M +17 +18 +16 +17
F +24 +21 +23 +23
Minimum M 710 711 711 713
F 715 719 719 719
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males from visit III (P50001), IV (P=0003), and V
(P=001) to VI. Among females, the symptom and
medication scores did not change significantly over the
follow-up.
Total asthma scores and medication scores tended to be
higher in the males than in the females over visits II to V
(significantly higher symptom scores in males at visit II,
P=0036), but at visit VI the reverse was found, i.e. all
scores tended to be higher in the female group.
The number of males without symptoms or medication
increased from one at visit II to seven at VI, to compare
with one woman at visit II and two women at VI. Six of the
nine subjects with an asthma score of 0 at visit VI were also
free from asthma at V.
HOSPITAL ADMISSIONS, EMERGENCY
VISITS AND SICK LISTING
A total of 148 admissions for asthma in 21 subjects were
recorded from birth up to the last follow-up with 98% of
the admissions recorded before the age of 16 years. During
adulthood there were only two admissions, one each for a
male and a female subject. During the period from birth to
5 years of age there was no gender dierence (53 admissions
in 14 subjects), whereas between 6 and 10 years of age nine
males had 38 admissions and three females had nine
admissions. Between 11 and 15 years of age, four males had
45 admissions and one female had one admission. An
emergency visit for asthma was done by three males andtwo females over the year prior to visit V and by one male
and two females during the year prior to VI. Three males
and two females were sick listed for asthma over the year
prior to visit V, in total 12 occasions. Over the year prior to
visit VI, one male only had been sick-listed for asthma on a
single occasion. All periods of sick-listing lasted less than 1
week.
MEDICATION FOR ASTHMA
Over the year before visit II, 15 subjects (27%) were on
continuous asthma medication. At visit III, 24 subjects
(44%) reported continuous medication to be compared
with nine subjects (16%) at visit VI (P50001; OR 150;
95%CI 16–3492). The most marked changes in medication
seen over the 21-year period were exchange of oral b2-
agonists for inhaled b2-agonists for occassional use, and
exchange of inhaled sodium cromoglycate for inhaled
corticosteroids for regular use. At the last follow-up, none
took regular inhalations of cromoglycate, in contrast to 19
subjects at visit III. At visit VI, inhaled corticosteroids were
used by seven subjects and another five subjects were
recommended regular steroid use.
GROWTH
Mean heights for the male and female participants did not
dier from Swedish normal standards (30) at visits II to V
(Table 2). Height was not below 719 SD in any patient at
any visit. Five males and three females showed an aberrant
growth pattern, defined as a drop in height by more than
one SDS between any two follow-up visits. In six subjects
(five with mild asthma at all visits) such a decrease in height
SDS occurred only between two subsequent follow-ups and
final height was above71 SDS. Only one male subject (final
height, 714 SDS) and one female (final height, 705 SDS)
deviated continuously from the expected growth channel
over several visits. The male patient had received repeated
courses of oral steroids due to numerous emergency visits
and the female patient had received local and short-term
oral steroids for rheumtaoid arthritis.
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Onset of eczema was before the age of 2 years in 23
(retrospective data) of the 29 subjects who ever had eczema.
In four subjects, eczema started after 7 years of age. The
current frequency of atopic eczema varied between 18 and
33% at the six visits. The current rate of eczema decreased
significantly from 33% at visit I to 18% at visit IV
(P=0001; OR 140; 95% CI 22–1154) ), and then
increased to 31% at visit VI (P50001). There were no
gender dierences either in current or cumulative rates of
eczema. Severe atopic dermatitis in terms of need for
frequent use of strong corticosteroid ointments and
inconvenience in daily life was found in one female and
one male subject at visit VI.
CLINICAL ALLERGY
There was no significant gender dierence in the rates of
allergy to pollens or furred animals at any visit.The course
of clinical allergy to pollens and danders is shown in Fig. 2
A–B. Significant increase in allergy to pollens occurred
from visit I (47%) to visit III (65%) for the whole groupFIG. 2. (A) Percentage of males, females and both with
reported allergy to pollens over visit I–VI. (B). Percentage
of males, females and both with reported allergy to furred
animals over visit I–VI.(P=0016; OR: 60, 95%CI: 128–3878), mainly due to an
increase for the males (P=0041). Significant decrease in
allergy to pollens occurred from visit III (65%) to V (47%;
P=0034, OR: 35, 95% CI 108–1256), mainly due to a
decrease for the males (P=0027, OR: 550, 95% CI: 116–
35.89). Clinical allergy to furred animals varied between
65% (visit I) and 78% (visit IV; n.s.).
At visit VI clinical allergy was found to nuts and/or
peanuts in 20 subjects (17 with a positive SPT to birch
pollen), to fruits in 17 subjects (15 with a positive SPT to
birch pollen) and to carrots in four subjects (all with a
positive SPT to birch pollen). Fifteen of these 21 subjects
reacted with oral allergy symptoms only. All 55 adult
subjects tolerated cow’s milk, and only one had an allergy
to eggs (RAST, 59 PRU ml71). Furthermore one subject
had a positive RAST to egg-white (10 PRU ml71).
SPT AND RAST TO INHALED ALLERGENS
The frequencies of a positive SPT and RAST at the six visits
to four common inhaled allergens are shown in Fig. 3 A–D.
The changes of the prevalence of a positive RAST were
analysed statistically only for visits III, IV, V and VI. There
were no gender dierences at any of the visits. The strength
of sensitization at each of visits III to VI was also estimated
by counting the number of positive SPTs to birch and
timothy and calculating the proportions of positive SPTs
out of all SPTs done to birch and timothy in females and
males, respectively. Similar proportions were calculated for
SPTs to three danders (cat, dog and horse), for RASTS to
three pollens (birch, hazel and timothy) and for RASTs to
three danders (cat, dog, horse). A significant gender
dierence in these proportions was found only once, at
visit IV, and concerned the proportions of positive SPTs to
pollens (males 64%, and females 41%; p=0023, OR; 26,
95%CI; 11–61). The rate of a positive SPT to birch pollen
varied between 49% at visit III and 64% at visit VI (n.s.)
and the rate of a positive RAST varied between 40% at visit
II and 53% at visit VI (n.s.). The frequency of a positive
SPT to timothy pollen varied between 55% at visit IV and
73% at visit III (n.s.) and the rate of a positive RAST to
timothy varied between 55% at visit II and 69% at visit III
(n.s.).
A significant decline of the rate of a positive RAST to cat
allergen class 3–4 was seen from visit III to VI (51–33%,
P=0039, OR; 40, 95%CI; 11–178). For dog allergen, we
found a significant (P50001, OR; 100, 95%CI; 23–619)
increase in the frequency of a positive SPT from visit III
(38%) to visit VI (71%), but over the same time period a
significant (P=0014, OR; 40, 95%CI; 13–141) decrease
was seen in the rate of a positive RAST from 60 to 47%.
There were no significant changes over time for the rates of
a positive SPT or RAST to horse or cow allergens.
The frequencies of a positive RAST to D. pteronyssinus at
visits II to VI were; 13, 27, 7, 11 and 16% (n.s.) The number
of subjects with a positive RAST of class 3–4 at any visit
were: 1, 2, 3 , 3, and 1. A positive RAST to D. farinae was
found in six subjects (11%) at any of visits IV, V or VI (only
tested at these visits), and in the same five subjects at all
FIG. 3. (A) Percentage of subjects with positive skin prick test (SPT) or RAST to birch pollen over visit I–VI. (B) Percentage
of subjects with positive skin prick test (SPT) or RAST to timothy pollen over visit I–VI. (C) Percentage of subjects with
positive skin prick test (SPT) or RAST to cat dander over visit I–VI. (D) Percentage of subjects with positive skin prick test
(SPT) or RAST to dog dander over visit I–VI.
460 B. KJELLMAN AND P. M. GUSTAFSSONthree visits. All except one of the 15 positive RASTs were
combined with a positive RAST to D. pteronyssinus.
Evaluation for a sensitization to L. destructor was
performed at visit V and disclosed only three subjects with
a positive RAST. The frequencies of a positive RAST to
moulds varied between 9 and 13% (n.s.).
RETAINING AND ADOPTING ALLERGY
AND TEST REACTIVITY
The retention rates of clinical allergy and test reactivity
between visit III at a median age of 13 years and at visit VI
at a median age of 30 years are shown in Table 3. The
number of subjects adopting or losing allergy or test
reactivity is also given. Some important additional results
are given here. The retention rate of clinical allergy from
visit I to VI was 54% for pollens and 89% for animals.
Twenty of the 21 subjects with both a positive SPT and
RAST to birch pollen at visit III retained both a positive
SPT and RAST at visit VI. Ten of the 13 subjects with a
clinical allergy to pollens at visit III but not at visit VIretained a positive SPT and RAST to birch and/or timothy
pollens at visit VI. Twenty-eight of the 30 subjects with
both a positive SPT and RAST to cat allergen at visit III
retained both a positive SPT and RAST at visit VI.
TOTAL SERUM–IGE
Total S-IgE concentrations are shown in Fig. 4. The
proportions of values above an arbitrary upper normal
limit of 100 kU l71 were at the five follow-up visits, 69 (42
samples available), 72, 64, 49 and 60%. There was no
gender dierence between median serum IgE concentra-
tions at any visit or between the number of males and
females with abnormally high values. At visit III, 14
subjects had IgE values above 500 kU l71 and 13 of them
continued to have values above 100 kU l71 throughout the
study. At visit III, 15 subjects had values below 100 kU l71
and 12 retained their values below 100 kU l71 throughout.
Twelve subjects (all with a positive SPT and RAST to both
pollens and danders) had IgE above 1000 kU l71 at one or
more visits, and in six of these subjects the values remained
at 500 kU l71 or more throughout the study.
TABLE 3. Clinical allergy and test reactivity in 55 subjects with childhood bronchial asthma. The number of subjects with
allergy to pollens or danders, and the number with positive skin prick test (SPT) or RAST at visits III (mean age 131 years)
and VI (mean age 301 years) are given. No. of subjects adopting, losing or retaining allergy or test reactivity between the visits
are also shown, as well as the retention rates















Pollens 36 27 4 13 23 64
Danders 40 43 6 3 37 93
Pos. SPT to
Birch 27 34 10 3 24 89
Timothy 41 37 2 6 35 85
Cat 34 40 8 2 32 94
Dog 22 39 19 2 20 91
Horse 36 33 4 7 29 81
Any mite 6 13 10 3 3 50
Any mould 2 8 7 1 1 50
Pos. RAST to
Birch 25 29 5 1 24 96
Timothy 38 34 4 8 30 79
Cat 39 37 3 5 34 87
Dog 32 26 3 9 23 72
Horse 33 28 6 11 22 67
D. Pter. 15 9 3 9 6 40
Any mould 21 6 1 15 5 24
FIG. 4. Total IgE serum concentrations over visit II–VI.
Median values and upper and lower quartiles are given.
ASTHMA FROM CHILDHOOD TO ADULTHOOD 461CLINICAL ALLERGY, SENSITIZATION AND
ASTHMA SEVERITY
Clinical allergy to animal danders and pollens, to danders
or pollens, or neither, was not associated to asthma
severity. An association was found between severity and
sensitization (RAST class2) to the most important
perennial allergens (cat, dog, horse); the proportion of
subjects sensitized to all three allergens was higher(P5001) among those with moderately severe or severe
asthma than among those with none or mild asthma at
visits IV (63 vs. 15%), V (41 vs. 3%) and VI (53 vs. 16%).
NON-ALLERGIC ASTHMA
Twelve subjects did not report an allergy to pollens and
eight subjects to danders. Six of the 55 subjects (11%) did
not report clinical allergy to pollens, danders or food at any
visit. They did not demonstrate atopic dermatitis at any
visit, with the exception of one subject, who had a mild and
local eczema on one occasion. One subject once had a
positive SPT to cat and a low RAST titre to dog and horse.
Two of the six subjects had had total serum IgE levels
above 100 kU l71 (maximum 239 kU l71). Asthma had
been severe (total asthma score 5–6) in two, moderate in
three (score 3–4) and mild in one subject. All six had been
passively exposed to tobacco smoke during early childhood
compared to 25 of the remaining 49 subjects (P=0030).
Four of the six had been exposed to furred animals in their
homes during childhood.
LIVING CONDITIONS, ALLERGEN AND
TOBACCO EXPOSURE
The change in living conditions over the 21 years was
similar in females and males (Table 4). The most obvious
462 B. KJELLMAN AND P. M. GUSTAFSSONchange was the decreased domestic exposure to tobacco
smoke and furred pets when the young adults moved away
from home.
Six women but no men were active smokers at the last
follow-up. CO in exhaled air from those who denied
smoking at visit VI varied between 2 and 6 p.p.m. The
values of the six smokers were: 38 p.p.m (20 cigarettes
daily), 30 p.p.m (20 cigarettes daily and smoking husband),
23 p.p.m (15 cigarettes daily), 15 p.p.m (20 cigarettes daily
and smoking husband), 12 p.p.m (10 cigarettes daily) and
4 p.p.m (10 cigarettes daily, but no smoking during 2 days
before examination). The three females who started
smoking in childhood continued smoking, while the two
males who smoked during childhood stopped smoking
before visit V.
By visit VI, at a mean age of 30 years, 45 subjects (82%)
were married or lived in a marriage-like relationship and 27
(49%) had at least one child of their own. There were no
gender dierences in the degree of education or sporting
activities. Five subjects (three males) had only compulsory
school education, while 60% had at least 3 years of high-
school training, and 12 females and nine males had
university training. None were unemployed at visit V but
five subjects (four females) reported that they were
unemployed at visit VI, none of them due to asthma. AtTABLE 4. Living conditions and exposure to furred animals and
childhood asthma, reported at six visits (visit no. I–VI) over 21
females (F) and both sexes combined
Living/exposure I
Rural living M 13
F 11
Both 24
One-family house M 26
F 20
Both 46






Cow house M 5
F 5
Both 10
Passive smoking M –
F –
Both –
Active smoking M 0
F 0
Both 0visits V and VI almost two-thirds of the subjects (similar for
males and females) reported regular physical sport activities
at least once a week. Such activities twice a week or more
were reported by 25 subjects (13 males) at visit V and 20
subjects (10 males) at visit VI.
Discussion
In this study on the course of asthma over two decades in
55 asthmatic children, who were 5–14 years old when
recruited, we found that asthma was initially more severe in
boys than in girls, despite them having been recruited on
the same criteria. The asthma course into adulthood was
characterized by:
. A decreasing severity of asthma from adolescence,
continuing in adulthood among the males but not in the
females.
. A final body height within normal limits in both sexes.
. High rates of clinical allergy and sensitisation to
pollens and furred animals and a high retention of
this allergy and sensitisation in adulthood, similar in
both sexes.
. A significant association between the extension of
sensitization to furred animals and asthma severity in
adulthood but not in childhood.tobacco smoke in 28 males (M) and 27 females (F) with
years. The number of subjects is given for males (M) and
Visit no.
II III IV V VI
14 13 10 6 5
12 11 7 7 9
26 24 17 13 14
27 26 24 8 10
21 23 15 6 16
48 49 39 14 26
7 6 4 1 3
8 7 4 1 3
15 13 8 2 6
2 1 1 1 0
5 3 3 1 3
7 4 4 2 3
5 4 2 1 1
3 3 3 0 1
8 7 5 1 2
16 16 6 — 0
15 15 7 — 2
31 31 13 — 2
1 2 1 0 0
2 3 4 5 6
3 5 5 5 6
ASTHMA FROM CHILDHOOD TO ADULTHOOD 463. Occurrence of non-allergic asthmatics (approximately
10%) who remained non-allergic and non-sensitized
during the whole study period.
. A substantial change for both sexes concerning living
conditions in terms of decreasing rates of indoor furred
animals and passive smoking.
. A successful social development concerning education,
employment and physical activities in both sexes.
The patients recruited to this study had all been referred
to the Central Hospital Outpatient Allergy Clinic from
general practitioners or paediatricians in the province
because of a history of three or more episodes of wheezing.
At that time, all children in this county were expected to be
referred for asthma and allergy evaluation when they
presented with such a history, and an evaluation of the
paediatric outpatient care in our area during the 1970s
indicated that these recommendations were actually fol-
lowed (32). We believe that the course of asthma in our
cohort well reflects the course in school children diagnosed
with asthma of various severity who attend a general
hospital paediatric clinic. Thus, the course and outcome of
our cohort dier from that of groups of infants and
toddlers with wheezy bronchitis who have higher rates of
remission (12), and also from population and birth cohort
studies.
In comparison to some other prospective studies, the
number of patients recruited to this study was low, and
non-significant dierences between, for example, males and
females must be judged with caution. Nevertheless, we feel
that the present study makes an important contribution to
the knowledge about the prospects for asthmatic children,
because all participants but one attended all five follow-up
visits, which is important in delineating a course. Detailed
information was obtained not only on asthma severity but
also on allergies, living conditions and life style, which
could influence the course of asthma. The interview
technique was uniform throughout the study, and one of
the authors (B.K.) supervised or took part in the evalua-
tions of all patients. Furthermore, the course of sensitiza-
tion was judged not only with SPT but also with RAST,
which is important since the quality of extracts used for
SPT has improved considerably over the study period. The
extracts used in the 1970s and during the first years of the
1980s were scarcely standardized, and the SPT results from
that time should be interpreted with caution.
ASTHMA SEVERITY
The asthma improvement judged both by scores and
hospital admissions for the whole group from childhood
to adulthood agrees with observations made by other
authors (25,26,33). A striking result was that statistically
significant improvement of asthma judged by scores was
limited to the males and that the non-significant tendency
to improvement in females ceased after the age of 20 years.
In a prospective long-term study from Melbourne, Kelly et
al. reported that asthma had worsened between the age of
21 and 28 years in 28% of the men and 19% of the women
(26), whereas Roorda et al. (34), who followed 406asthmatic children to an age of 21–29 years, found that
the men had more symptoms than the women at that age.
In a questionnaire follow-up study of children from
Tasmania, Jenkins et al. reported that being female was
the most common risk factor for having asthma as an adult
(35). Also, in a re-investigation of asthmatic children at an
age of 22–33 years, Gerritsen and co-workers found that
the women tended to have a higher rate of current
symptoms (36).
The more favourable course and outcome among the
men than among the women could not be explained by less
domestic allergen exposure, dierent medication or better
social course and outcome, nor by a lower degree of clinical
allergy or sensitization to common inhaled allergens.
Neither could it be explained by more favourable living
conditions during childhood. A diverging factor was that
all adult males were non-smokers, whereas six adult females
were moderate cigarette smokers. These females had only
mild or moderate asthma, and an exclusion of them from
the calculations did not change the trends but they reported
slightly higher symptom scores and somewhat lower
medication scores than the non-smoking women. Whether
this gender dierence in the course of asthma severity is
supported by lung function data is analysed in the
companion paper (28).
Despite asthma improvement for the group as a
whole, only nine subjects (16%) had been free from
asthma symptoms and medication during the year
prior to the last follow-up. If the criterion for complete
remission of asthma is absence of symptoms and
medication both at the last and the penultimate visit,
only six of the 55 participants (11%) would be considered
free from asthma. Cure rates of 20–80% have
been reported, and dierences in, for example, the
definitions of cure, severity of asthma at inclusion,
environmental factors, and techniques for follow-up (e.g.
interview or self-administered questionnaires) presumably
account for this variability (23,24). These high rates of
persistent asthma may reflect the base for recruitment (a
hospital outpatient clinic) and the fact that all participants
were interviewed.
The aim with medication was similar throughout the
study period but marked changes were seen in the use of
dierent pharmaceutical agents and in the routes of
administration, reflecting the ‘historical’ development in
this field. The contribution of such changes to the course of
asthma in this cohort cannot be estimated, but apparently
the change of medication did not withhold the tendency to
worsening of the asthma among the adult females.
ALLERGY AND SENSITIZATION
The preponderance of sensitization to pollens and animal
danders over mites and moulds agrees with previous studies
from inland or northern areas of Sweden (37,38) and with
the results in some cohorts of children from our province
followed from birth to middle school age (9,10). Tolerance
to inhaled allergens developed only in a few subjects from
childhood to adulthood, with either being judged from
464 B. KJELLMAN AND P. M. GUSTAFSSONclinical symptoms: SPT, RAST, or SPT and RAST. The
fact that the great majority of the subjects did not have
domestic contact with furred animals after adolescence did
not result in lowered sensitization rates to such animals.
Low-dose exposure from indirect contacts with animal
danders is frequent, and thus seems able to maintain clinical
allergy and sensitization (39–41). The improvement of
asthma symptoms seen from childhood to adulthood
cannot be explained by development of tolerance to inhaled
allergens, but the reduced domestic exposure to furred
animals after childhood, similar in both sexes, may have
contributed to the improvement.
The low rate of clinical allergy and sensitization to egg
allergens, found in adulthood, fits well with findings in
previous studies of an early development of tolerance to
such allergens and that this tolerance remains (9,10). The
high incidence in adulthood of clinical allergy to nuts,
peanuts and fruits with an association to birch pollen
sensitization and with a dominance of solely an oral allergy
syndrome is consistent with previous observations (42–45).
The genetic influence on the IgE production is obvious
from the fact that high levels of serum total IgE mostly
remained high, and low values remained low during the
whole follow-up. The genetic heterogeneity of childhood
asthma is illustrated by the fact that six subjects never
developed clinical allergy and that five of these never had
evidence of sensitization. The occurrence of a non-allergic
asthma has been reported previously (20,21), and the
present finding that approximately 10% of the children
remained non-allergic and non-sensitized over such a long
period with repeated checks is a strong evidence of the
existence of a true non-allergic type of asthma in school-
aged children.
LIVING CONDITIONS
The high number of subjects living in rural area, in one-
family houses and with daily contact with furred animals
during childhood and youth agrees well with the results that
we obtained in an inquiry among all 40 000 school children
in our province in the late 1970s (1). Our routine
recommendations since the 1970s to avoid keeping furred
pets in the homes of asthmatic children were only partly
acted upon during childhood and adolescence. Our general
impression of good social adaptation in adult life was
supported by the data on education, the low unemployment
rate and the high rate of physical exercise. The percentage
of subjects with university training was slightly higher than
average for our province, and the unemployment rate was
slightly below Swedish national figures from that time. Our
finding of a good social adaptation agrees with the report
from Ross et al. (46).
CONCLUSIONS
This study has shown that asthma generally improves from
childhood to adulthood, that clinical allergies and sensitiza-
tion to inhaled allergens generally persist, and that the
social outcome is good. While asthma continuous toimprove after adolescence in the males, it seems to worsen
among the females, and this dierence cannot be explained
by gender dierences in the presence and course of clinical
allergies, sensitization to common inhaled allergens, or
social and environmental conditions.
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